Bellerophon Therapeutics Priced, Nasdaq: BLPH

Developing drug-device therapies for pulmonary and cardiac diseases.

Industry: Health Care

Latest Trade: $1.45 0.00 (0.0%)

First Day Return: -25.3%

Return from IPO: -87.9%

Industry: Health Care

We are a clinical-stage therapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary and cardiac diseases. We have two programs in advanced clinical development. The first program, INOpulse, is based on our proprietary pulsatile nitric oxide delivery device. We are currently developing two product candidates under our INOpulse program: one for the treatment of pulmonary arterial hypertension, for which we intend to commence Phase 3 clinical trials in the second half of 2015, and the other for the treatment of pulmonary hypertension associated with chronic obstructive pulmonary disease, or PH-COPD, which is in Phase 2 development. Our second program is bioabsorbable cardiac matrix, which is currently in a placebo-controlled clinical trial designed to support CE mark registration in the European Union. We completed enrollment of this trial in December 2014, with 303 patients having completed the treatment procedure, and we expect to report top line results in mid-2015. Assuming positive results, we intend to conduct a pivotal pre-market approval trial of BCM beginning in the first half of 2016, which will be designed to support registration in the United States. We are developing BCM for the prevention of cardiac remodeling, which often leads to congestive heart failure following an ST-segment elevated myocardial infarction.
more less
IPO News for Bellerophon Therapeutics
more
IPO Data
IPO File Date 01/13/2015
Offer Price $12.00
Price Range $14.00 - $16.00
Offer Shares (mm) 5.0
Deal Size ($mm) $60
IPO Data
IPO Date 02/13/2015
Offer Price $12.00
Price Range $14.00 - $16.00
Offer Shares (mm) 5.0
Deal Size ($mm) $60
Underwriters
more
Company Data
Headquarters Hampton, NJ
Founded 2013
Employees 48
Website www.bellerophon.com